Jim Heller Discusses Philadelphia Pelvic Mesh Verdict

Thursday, February 11, 2016

Jim Heller, chair of Cozen O'Connor's Products Liability practice, discusses the impact of the Philadelephia pelvic mesh verdict on Johnson & Johnson in Law360. After two consecutive jury verdicts exceeding $12 million, Johnson & Johnson may think seriously about settling roughly 150 cases remaining in the jurisdiction’s mass tort program and focusing on the much larger federal multi-district litigation. To turn the course of the litigation in its favor, J&J is likely looking for one of two developments in its appeals of both Philadelphia verdicts, according to Jim. The first would be a defense verdict that gives it more leverage in any negotiations. The second would be a decision — ideally from an appellate court — that some of the evidence presented by the plaintiffs was inadmissible. 

To read the article, click here.


James H. Heller

Co-Chair, Commercial Litigation Department
Chair, Product Liability


(215) 665-2189


Related Practice Areas

Keep up-to-date with the latest news from Cozen O'Connor

Enter your City or Zip.

Probably shouldn't change this:
Sign up to receive alerts, publications, and event / webinar invites.

By submitting your contact information, you are giving Cozen O'Connor consent to contact you via email.